TI
GOSS icon

Trexquant Investment’s Gossamer Bio GOSS Stock Holding History

Trexquant Investment’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,378
Closed -$171K – 1545
2022
Q2 		$171K Sell
20,378
-8,683
-30% -$67.3K 0.01% 1385
2022
Q1 		$252K Buy
29,061
+14,162
+95% +$137K 0.01% 1089
2021
Q4 		$169K Sell
14,899
-3,940
-21% -$46.8K 0.01% 1179
2021
Q3 		$237K Buy
+18,839
New +$173K 0.02% 874
2021
Q1 		– Sell
-16,555
Closed -$160K – 1244
2020
Q4 		$160K Sell
16,555
-4,380
-21% -$43.1K 0.02% 926
2020
Q3 		$260K Buy
+20,935
New +$278K 0.02% 983
2020
Q2 		– Sell
-13,492
Closed -$137K – 1271
2020
Q1 		$137K Buy
+13,492
New +$176K 0.01% 1021

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Trexquant Investment's GOSS Position: Q3 2022 in Review

Trexquant Investment sold out of Gossamer Bio (GOSS) in Q3 2022, closing a stake of 20,378 shares — an estimated $171K sold.

Trexquant Investment first reported a position in GOSS in Q1 2020 and held it in 7 quarters. The position peaked at $260K in Q3 2020. 160 funds tracked by Wall St. Rank hold GOSS as of Q3 2022.

  • Trexquant Investment reported no remaining Gossamer Bio position as of Q3 2022 after selling out during the quarter.
  • Trexquant Investment sold 20,378 Gossamer Bio shares in Q3 2022, an estimated $171K.
  • Trexquant Investment first reported a position in Gossamer Bio in Q1 2020 and held it in 7 quarters.
  • Trexquant Investment's Gossamer Bio position peaked at $260K in Q3 2020.
  • 160 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2022.

Based on Trexquant Investment's 13F filing for Q3 2022, filed 14 Nov 2022.